Potenza Therapeutics potenzatherapeutics.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Potenza Therapeutics is a preclinical stage biotechnology company that is focused on cancer immunotherapy. Potenza is discovering and developing therapeutics that stimulate a patients immune system to seek out and destroy cancerous cells.

Potenza Therapeutics is a preclinical stage biotechnology company that is focused on cancer immunotherapy. Potenza is discovering and developing therapeutics that stimulate a patients immune system to seek out and destroy cancerous cells.

Company (Alive / Active)

Phone: 617-588-4150

Fax:

1030 Massachusetts Ave
Suite 210
Cambridge, 02138
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Potenza Therapeutics $35M Dec 29, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Potenza Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
MPM CapitalVenture CapitalCambridge, Massachusetts, United StatesSeries A - II, Series A
InterWest PartnersVenture CapitalMenlo Park, California, United StatesSeries A - II, Series A
Astellas Venture ManagementCorporate VentureMenlo Park, California, United StatesSeries A - II
See all 3 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Anti-tigit antigen-binding proteins and methods of use thereof Feb 13, 2017 Jul 25, 2017 Patent
Anti-tigit antigen-binding proteins and methods of use thereof Jun 19, 2017 Application